DK0687253T3 - Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelser - Google Patents
Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelserInfo
- Publication number
- DK0687253T3 DK0687253T3 DK94909909T DK94909909T DK0687253T3 DK 0687253 T3 DK0687253 T3 DK 0687253T3 DK 94909909 T DK94909909 T DK 94909909T DK 94909909 T DK94909909 T DK 94909909T DK 0687253 T3 DK0687253 T3 DK 0687253T3
- Authority
- DK
- Denmark
- Prior art keywords
- stands
- atom
- compounds
- hydrogen
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4306506A DE4306506A1 (de) | 1993-03-03 | 1993-03-03 | Neue 4-Alkylaminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| DE19934312966 DE4312966A1 (de) | 1993-04-21 | 1993-04-21 | Neue 4-Aminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| PCT/EP1994/000608 WO1994020467A1 (de) | 1993-03-03 | 1994-03-02 | Neue 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0687253T3 true DK0687253T3 (da) | 1999-08-23 |
Family
ID=25923593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94909909T DK0687253T3 (da) | 1993-03-03 | 1994-03-02 | Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelser |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0687253B1 (hu) |
| JP (1) | JPH08507503A (hu) |
| KR (1) | KR100252551B1 (hu) |
| CN (1) | CN1046710C (hu) |
| AT (1) | ATE174590T1 (hu) |
| AU (1) | AU682026B2 (hu) |
| CA (1) | CA2156729A1 (hu) |
| CZ (1) | CZ225495A3 (hu) |
| DE (1) | DE59407494D1 (hu) |
| DK (1) | DK0687253T3 (hu) |
| ES (1) | ES2127919T3 (hu) |
| FI (1) | FI954105A0 (hu) |
| GR (1) | GR3029691T3 (hu) |
| HU (1) | HUT72898A (hu) |
| IL (1) | IL108786A (hu) |
| NO (1) | NO953447L (hu) |
| NZ (1) | NZ262725A (hu) |
| PL (1) | PL176455B1 (hu) |
| RU (1) | RU2126388C1 (hu) |
| SK (1) | SK108295A3 (hu) |
| TW (1) | TW257757B (hu) |
| WO (1) | WO1994020467A1 (hu) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4430755A1 (de) * | 1994-08-30 | 1996-03-07 | Boehringer Mannheim Gmbh | Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US5792769A (en) * | 1995-09-29 | 1998-08-11 | 3-Dimensional Pharmaceuticals, Inc. | Guanidino protease inhibitors |
| GB9525620D0 (en) | 1995-12-15 | 1996-02-14 | Glaxo Group Ltd | Chemical compounds |
| DE69631692T2 (de) | 1995-12-29 | 2004-12-02 | 3-Dimensional Pharmaceuticals, Inc. | Amidino proteaseinhibitoren |
| GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
| JP2000504336A (ja) | 1996-02-02 | 2000-04-11 | ゼネカ・リミテッド | 薬学製剤として有用なヘテロ環式化合物 |
| SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
| US6093718A (en) * | 1996-08-14 | 2000-07-25 | Zeneca Limited | Substituted pyrimidine derivatives and their pharmaceutical use |
| JP2001500864A (ja) * | 1996-09-13 | 2001-01-23 | メルク エンド カンパニー インコーポレーテッド | トロンビン阻害物質 |
| GB9821483D0 (en) | 1998-10-03 | 1998-11-25 | Glaxo Group Ltd | Chemical compounds |
| UA56197C2 (uk) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
| WO1998024760A1 (en) * | 1996-12-03 | 1998-06-11 | Graybill Todd L | Aminobenzenedicarboxylic acid-based combinatorial libraries |
| AU5999698A (en) | 1997-02-13 | 1998-09-08 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| AU5999798A (en) | 1997-02-13 | 1998-09-08 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| JP4327915B2 (ja) * | 1998-03-30 | 2009-09-09 | 株式会社デ・ウエスタン・セラピテクス研究所 | スルフォンアミド誘導体 |
| DE69923467D1 (de) | 1998-10-06 | 2005-03-03 | Dainippon Pharmaceutical Co | 2,3-disubstituierte pyridinderivate, verfahren zur derren herstellung, sie enthaltende wirkstoffzubereitungen und zwischenprodukte für die herstellung |
| GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| MXPA03000963A (es) | 2000-08-04 | 2004-04-05 | Dimensional Pharm Inc | Inhibidores de oxiguanidina ciclica proteasa. |
| US6849635B2 (en) * | 2001-05-07 | 2005-02-01 | Smithkline Beecham Corporation | Sulfonamides |
| US20050043536A1 (en) * | 2001-05-07 | 2005-02-24 | Dashyant Dhanak | Sulfonamides |
| AU2003250197B2 (en) * | 2002-08-27 | 2009-11-12 | Merck Patent Gmbh | Glycinamide derivatives as raf-kinase inhibitors |
| CA2499490A1 (en) | 2002-09-20 | 2004-04-01 | Pfizer Products Inc. | Amide and sulfonamide ligands for the estrogen receptor |
| WO2005049573A1 (en) | 2003-11-05 | 2005-06-02 | F. Hoffmann-La Roche Ag | Phenyl derivatives as ppar agonists |
| US8940900B2 (en) * | 2007-02-28 | 2015-01-27 | Advinus Therapeutics Private Limited | 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| RU2353619C2 (ru) * | 2007-06-28 | 2009-04-27 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции |
| RU2354647C2 (ru) * | 2007-06-28 | 2009-05-10 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815784D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| US8265575B2 (en) * | 2009-06-16 | 2012-09-11 | Mediatek Inc. | Methods for handling a transmitting process and communication apparatuses utilizing the same |
| US8207639B2 (en) | 2009-10-23 | 2012-06-26 | Sunonwealth Electric Machine Industry Co., Ltd. | Motor and heating dissipating fan including motor having an annular balancing member |
| RU2685261C1 (ru) * | 2018-04-05 | 2019-04-17 | Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" | Вещество 4-амино-1-{ 2-[3-метил-5-(бензолсульфонилокси)фенокси] этил} -пиридиний хлорид, обладающее свойствами биологически активного агента, влияющими на естественно текущие процессы свертываемости крови млекопитающих, антикоагулянт на его основе и способ его получения путем химического синтеза |
| CN109172573B (zh) * | 2018-09-12 | 2021-01-26 | 黑龙江中桂制药有限公司 | 一种口服抗血栓药物及其用途 |
| CN110669337B (zh) * | 2019-07-08 | 2020-09-25 | 中国科学院长春应用化学研究所 | 一种芳香型二胺单体及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8819307D0 (en) * | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Antiarrhythmic agents |
| JPH0256465A (ja) * | 1988-08-22 | 1990-02-26 | Hamari Yakuhin Kogyo Kk | アセトアミド化合物 |
| EP0610432A1 (en) * | 1991-10-31 | 1994-08-17 | Smithkline Beecham Corporation | C8-cyclic peptidomimetics as fibrinogen antagonists |
| WO1993010091A2 (en) * | 1991-11-14 | 1993-05-27 | Glaxo Group Limited | Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| DE4212304A1 (de) * | 1992-04-13 | 1993-10-14 | Cassella Ag | Asparaginsäurederivate, ihre Herstellung und Verwendung |
-
1994
- 1994-02-22 TW TW083101504A patent/TW257757B/zh active
- 1994-02-28 IL IL10878694A patent/IL108786A/en not_active IP Right Cessation
- 1994-03-02 PL PL94310520A patent/PL176455B1/pl unknown
- 1994-03-02 AU AU62574/94A patent/AU682026B2/en not_active Ceased
- 1994-03-02 DE DE59407494T patent/DE59407494D1/de not_active Expired - Fee Related
- 1994-03-02 CN CN94191554A patent/CN1046710C/zh not_active Expired - Fee Related
- 1994-03-02 WO PCT/EP1994/000608 patent/WO1994020467A1/de not_active Application Discontinuation
- 1994-03-02 ES ES94909909T patent/ES2127919T3/es not_active Expired - Lifetime
- 1994-03-02 KR KR1019950703694A patent/KR100252551B1/ko not_active IP Right Cessation
- 1994-03-02 RU RU95122612A patent/RU2126388C1/ru active
- 1994-03-02 JP JP6519556A patent/JPH08507503A/ja active Pending
- 1994-03-02 HU HU9502568A patent/HUT72898A/hu unknown
- 1994-03-02 SK SK1082-95A patent/SK108295A3/sk unknown
- 1994-03-02 NZ NZ262725A patent/NZ262725A/en unknown
- 1994-03-02 EP EP94909909A patent/EP0687253B1/de not_active Expired - Lifetime
- 1994-03-02 DK DK94909909T patent/DK0687253T3/da active
- 1994-03-02 CZ CZ952254A patent/CZ225495A3/cs unknown
- 1994-03-02 AT AT94909909T patent/ATE174590T1/de not_active IP Right Cessation
- 1994-03-02 CA CA002156729A patent/CA2156729A1/en not_active Abandoned
-
1995
- 1995-09-01 FI FI954105A patent/FI954105A0/fi unknown
- 1995-09-01 NO NO953447A patent/NO953447L/no unknown
-
1999
- 1999-03-16 GR GR990400775T patent/GR3029691T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3029691T3 (en) | 1999-06-30 |
| FI954105A (fi) | 1995-09-01 |
| ES2127919T3 (es) | 1999-05-01 |
| CN1046710C (zh) | 1999-11-24 |
| HUT72898A (en) | 1996-06-28 |
| ATE174590T1 (de) | 1999-01-15 |
| KR960701019A (ko) | 1996-02-24 |
| RU2126388C1 (ru) | 1999-02-20 |
| NZ262725A (en) | 1997-05-26 |
| AU682026B2 (en) | 1997-09-18 |
| CZ225495A3 (en) | 1996-01-17 |
| SK108295A3 (en) | 1996-06-05 |
| PL310520A1 (en) | 1995-12-27 |
| JPH08507503A (ja) | 1996-08-13 |
| FI954105A0 (fi) | 1995-09-01 |
| IL108786A0 (en) | 1994-06-24 |
| EP0687253B1 (de) | 1998-12-16 |
| CA2156729A1 (en) | 1994-09-15 |
| HU9502568D0 (en) | 1995-11-28 |
| KR100252551B1 (ko) | 2000-05-01 |
| AU6257494A (en) | 1994-09-26 |
| WO1994020467A1 (de) | 1994-09-15 |
| PL176455B1 (pl) | 1999-05-31 |
| IL108786A (en) | 1999-04-11 |
| NO953447D0 (no) | 1995-09-01 |
| EP0687253A1 (de) | 1995-12-20 |
| DE59407494D1 (de) | 1999-01-28 |
| TW257757B (hu) | 1995-09-21 |
| NO953447L (no) | 1995-09-01 |
| CN1119858A (zh) | 1996-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0687253T3 (da) | Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelser | |
| ZA919181B (en) | Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them | |
| NO944700L (no) | Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene | |
| DK0667852T3 (da) | Hidtil ukendte 3,3-diphenylpropylaminer samt deres anvendelse og fremstilling | |
| DK0457686T3 (da) | Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| WO1998009953A3 (de) | Azinyloxy- und phenoxy-diaryl-carbonsäure derivate, deren herstellung und deren verwendung als gemischte eta/etb endothelin-rezeptorantagonist | |
| NO922185L (no) | 1-metylkarbapenemderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som antibiotika | |
| MX9700928A (es) | Derivado de triazian y medicina que lo contiene. | |
| DK0488513T3 (da) | Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen | |
| DK492288D0 (da) | Amidforbindelser, farmaceutisk praeparat indeholdende samme samt fremgangsmaade til fremstilling af forbindelserne | |
| HUP0004588A2 (hu) | Szubsztituált 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-ol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerként, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| AR029618A1 (es) | Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos | |
| TW259785B (en) | Chemical compounds | |
| PL326554A1 (en) | Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase | |
| DE59007487D1 (de) | Hydroxyalkancarbonsäure-derivate und deren verwendung. | |
| ZA918991B (en) | Imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them | |
| ATE86993T1 (de) | Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
| DK614989A (da) | Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
| HUT58273A (en) | Process for producing aminoketon compounds and pharmaceutical compositions containing them | |
| NO920619L (no) | Oxazinobenzazolforbindelser | |
| BR9812928B1 (pt) | derivados de 3-oxo-(2h)-1,2,4-triazina, compostos, processo de preparaÇço de compostos quÍmicos, e, composiÇço farmacÊutica. | |
| DK104488D0 (da) | Acetamider afledt af 2,3-dihydro-3-phenyl-2-benzofuranon, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem | |
| MX9703112A (es) | Nitro-benzamidas utiles como agentes antiarritmicos. | |
| DK503683A (da) | Fremgangsmaade til fremstilling af derivater af gamma-butyrolacton, som er myocardiebeskyttelsesmidler med en antiarytmisk virkning |